The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
High-dose melphalan with autologous bone marrow transplantation for multiple myeloma
Open accessAbstract
A large dose of melphalan was given to 23 patients with advanced multiple myeloma that was refractory to multiple prior treatments. Sixteen patients received a dose of 80 to 100 mg/m2, and seven were given 140 mg/m2 followed by autologous bone marrow infusion. Tumor mass was reduced by more than 75% in 14 patients, including four who died of bone marrow aplasia. Serious infections were prevented in six of seven patients who received autologous bone marrow. The marked cytoreduction in patients with previously refractory disease indicated the apparent drug resistance could be overcome by dose escalation. However, short remission times in most responding patients were consistent with rapid regrowth of primordial tumor cells with high proliferative activity. Although high-dose melphalan was of limited benefit to patients with refractory myeloma, further studies are necessary to clarify its role during earlier phases of disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents
Barlogie, B., Smith, L., & Alexanian, R. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405243102104 · Cited by 641
Self-citationHIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMA
MCELWAIN, T. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90739-0 · Cited by 510
Prognostic factors in multiple myeloma
Alexanian, R., Balcerzak, S., Bonnet, J. D., Gehan, E. A., Haut, A., Hewlett, J. S., & Monto, R. W. (1975) · Cancer · doi:10.1002/1097-0142(197510)36:4<1192::aid-cncr2820360403>3.0.co;2-i · Cited by 229
Self-citationIdentification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
Caligaris‐Cappio, F., Bergui, L., Tesio, L., Pizzolo, G., Malavasi, F., Chilosi, M., Campana, D., Camp, B. V., & Janossy, G. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112080 · Cited by 146
Ploidy and proliferative characteristics in monoclonal gammopathies
Latreille, J., Barlogie, B., Johnston, D., Drewinko, B., & Alexanian, R. (1982) · Blood · doi:10.1182/blood.v59.1.43.43 · Cited by 144
Self-citationMarrow cytometry and prognosis in myeloma.
Barlogie, B., Alexanian, R., Gehan, E. A., Smallwood, L., Smith, T., & Drewinko, B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111056 · Cited by 48
Self-citation
Cited by
Attal, M., Harousseau, J.-L., Stoppa, A.-M., Sotto, J.-J., Fuzibet, J.-G., Rossi, J.-F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607113350204 · Cited by 2,548
Fermand, J.-P., Ravaud, P., Chevret, S., Divine, M., Leblond, V., Belanger, C., Macro, M., Pertuiset, E., Dreyfus, F., Mariette, X., et al. (1998) · Blood · doi:10.1182/blood.v92.9.3131 · Cited by 542
Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma
Barlogie, B., Jagannath, S., Desikan, K. R., Mattox, S., Vesole, D., Siegel, D., Tricot, G., Munshi, N., Fassas, A., Singhal, S., et al. (1999) · Blood · doi:10.1182/blood.v93.1.55.401k04_55_65 · Cited by 502
Self-citationPaiva, B., Vidriales, M.-B., Cerveró, J., Mateo, G., Pérez, J. J., Montalbán, M. A., Sureda, A., Montejano, L., Gutiérrez, N. C., de Coca, A. G., et al. (2008) · Blood · doi:10.1182/blood-2008-05-159624 · Cited by 477
Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma
Barlogie, B., Jagannath, S., Desikan, K. R., Mattox, S., Vesole, D., Siegel, D., Tricot, G., Munshi, N., Fassas, A., Singhal, S., et al. (1999) · Blood · doi:10.1182/blood.v93.1.55 · Cited by 472
Self-citation
Metadata
- Authors
- Barlogie, B., Hall, R., Zander, A., Dicke, K., & Alexanian, R.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1986-05-01
- Volume
- 67
- Issue
- 5
- Pages
- 1298-1301
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1233091556
- Cited by
- 340
- References
- 6
- FWCI
- 9.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. https://app.cochat.ai/papers/10.1182/blood.v67.5.1298.1298
- The paper
- Barlogie, B., Hall, R., Zander, A., Dicke, K., & Alexanian, R. (1986). High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood. https://doi.org/10.1182/blood.v67.5.1298.1298
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.